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ABSTRACT 
 
Aim: To determine the role of NOTCH during the arterial injury response and the subsequent chronic 
arterial-wall inflammation underlying atherosclerosis. 
Methods and results: We have generated a mouse model of endothelial-specific (Cdh5-driven) depletion 
of the Notch effector RBPJ (ApoE-/-;RBPJflox/flox;Cdh5-CreERT). Endothelial-specific deletion of RBPJ or 
systemic deletion of Notch1 in athero-susceptible ApoE-/- mice fed a high cholesterol diet for 6 weeks 
resulted in reduced atherosclerosis in the aortic arch and sinus. Intravital microscopy revealed decreased 
leukocyte rolling on the endothelium of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice, correlating with a lowered 
content of leukocytes and macrophages in the vascular wall. Transcriptome analysis revealed 
downregulation of proinflammatory and endothelial activation pathways in atherosclerotic tissue of 
RBPJ-mutant mice. During normal Notch activation, Jagged1 signalling upregulation in endothelial cells 
promotes nuclear translocation of the Notch1 intracellular domain (N1ICD) and its physical interaction 
with NF-B. This N1ICD–NF-B interaction is required for reciprocal transactivation of target genes, 
including vascular cell adhesion molecule-1 (Vcam1).  
Conclusions: Notch signalling pathway inactivation decreases leukocyte rolling, thereby preventing 
endothelial dysfunction and vascular inflammation. Attenuation of Notch signalling might provide a 
treatment strategy for atherosclerosis.  
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Nonstandard Abbreviations and Acronyms 
ApoE Apolipoprotein E  
BAEC Bovine Aortic Endothelial Cell 
CAD coronary artery disease 
Cdh5-CreERT Cadherin 5-CreERT, tamoxifen inducible driver mice 
DAPT γ -secretase/Notch signalling pathway inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester 
DMSO dimethyl sulfoxide 
HCD High cholesterol diet 
HUVEC Human Umbilical Vein Endothelial Cells 
Ikbka Inhibitor of Kappa Light Polypeptide Gene Enhancer in B Cells  
NECD Notch extracellular domain 
NF-κB Nuclear factor-κB 
NICD Notch intracellular domain  
Notch1+/- Heterozygous Notch1 mutant mice 
PAEC Porcine Aortic Endothelial Cells 
RBPJ recombination signal binding protein for immunoglobulin kappa J region 
RBPJ+/- Heterozygous RBPJ mutant mice 
RBPJflox/flox  Homozygous RBPJk conditional mice 
RO γ-secretase/Notch signalling pathway inhibitor RO4929097 
TNF Tumor necrosis factor alpha 
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Introduction 
 The endothelium plays a central role in vascular physiology, and endothelial dysfunction is 
intimately associated with vascular disease 1-3. Endothelial dysfunction is often preceded by “activation”, 
characterized by the induction of proinflammatory signalling cascades and increased expression of 
vascular adhesion molecules on the endothelial cell surface. These events stimulate the recruitment of 
leukocytes to the arterial wall and the initiation of the inflammatory and immune processes that promote 
atheroma initiation and progression in humans and mice. 4-6  
Notch is a highly conserved intercellular signalling pathway that regulates many aspects of 
organismal development and postnatal tissue homeostasis 7. Notch receptors (Notch 1-4), are expressed at 
the cell surface as heterodimers consisting of an extracellular region (NECD) and a membrane-tethered 
intracellular domain (NICD). The NECD interacts with membrane-bound ligands of the Delta-like (Dll1, 
Dll3, and Dll4) and Jagged (Jag 1 and Jag2) families expressed on adjacent cells, triggering a series of 
cleavages in the NICD. Cleavage by the -secretase complex releases NICD, which is then translocated to 
the nucleus 8. In the nucleus, the NICD forms a complex with the RBPJ/CSL effector transcription factor, 
resulting in activation of target genes, including those encoding the Hes and Hey families of 
transcriptional repressors 9.  
Notch pathway elements are expressed broadly in the vascular endothelium and smooth muscle 
from early developmental stages 10, 11. Their function is to maintain proper artery, capillary and vein 
organization 12 and to regulate vascular smooth muscle cell differentiation and the response to vascular 
injury 11, 13. Notch pathway elements are activated after experimentally induced vascular injury 14, 15, and 
blockade of Notch signalling compromises vascular repair and pathological remodeling 1617, 18, 
underscoring the importance of this pathway in maintaining vascular wall homeostasis.  
 We found multiple components of the NOTCH pathway to be upregulated in human 
atherosclerotic lesions and in the hyperlipidemic apolipoprotein E–knockout (ApoE-/-) mouse model of 
atherosclerosis, suggesting an important function for NOTCH signalling during the chronic inflammation 
underlying atherosclerosis. To study the contribution of NOTCH signalling to this process, we combined 
genetic models of systemic (RBPJ+/- and Notch1+/-) and endothelial-specific (RBPJflox/flox;Cdh5-CreERT/+) 
Notch deficiency with the ApoE-/- mouse model. We show that canonical Notch deficiency in the 
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endothelium of cholesterol-fed ApoE-/- mice decreases atherosclerosis, secretion of inflammation-related 
factors, and leukocyte recruitment to the arterial wall. Transcriptome analysis indicates that endothelial 
Notch-RBPJ signalling favours disease progression during atherosclerosis through a process largely 
driven by NF-B-mediated inflammation. We also show that N1ICD binds to both IKKα and NF-kB-
p65, and that its interaction with NF-kB-p65 is enhanced by proinflammatory signals and promotes 
nuclear localization in endothelial cells. We propose that synergy between Notch and NF-kB signalling in 
the endothelium ensures an adequate inflammatory response by promoting robust and sustained bi-
directional target gene transactivation. Given the strong activation of NOTCH signalling in 
atherosclerotic coronary arteries of CAD patients, attenuating NOTCH signalling in the endothelium 
represents a potential therapeutic strategy for CAD.  
 
Material and Methods 
Materials and Methods are available in the online Data Supplement. 
 
Results 
Enhanced expression of Notch pathway components in human and mouse atherosclerotic lesions  
To explore the clinical relevance of the Notch pathway during atherosclerosis we examined the 
expression of NOTCH pathway components in human atherosclerotic coronary arteries. Western blot 
analysis revealed markedly increased protein levels of NOTCH1 (full-length and cleaved), JAG1, and 
HES1 in atherosclerotic coronary arteries from coronary artery disease (CAD) patients (Figure 1A). qRT-
PCR analysis revealed corresponding increases in NOTCH1, JAG1 and HES1 mRNA expression (Figure 
1B). These data highlight the clinical importance of Notch signalling activation in CAD. 
Similar results were obtained upon examination of aortic-root cross-sections from C57BL/6 control mice 
and ApoE-/- mice fed a high-cholesterol diet (HCD) for 6 weeks. Thus, Jagged1, Notch1, NICD and Hes1 
were all upregulated in the endothelium of ApoE-/- mice at atherosclerotic and non-atherosclerotic plaque 
sites (Figure 1, C-F). The expression of Dll4, Notch2, Notch4 and Hey1 was increased although more 
readily within cells located inside the atherosclerotic plaque (Supplementary material online, Figure S1A-
D). Exposing mouse ApoE-/- aortic endothelial cells (MAEC) to the pro-inflammatory cytokine TNF 
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strongly upregulated the expression of Notch1-4, Jag1, Hes1, Hey1 and Hey2 mRNA, but not Dll4 
(Supplementary material online, Figure S1E). Western blot confirmed TNF-induced increases in Jag1 
and Hes1 protein expression (Supplementary material online, Figure S1F). Oxidation of low-density 
lipoproteins (LDL) is a primary factor triggering atherogenesis 19. To examine the effect of ox-LDL in 
vitro, MAECs were exposed to a sub-apoptotic concentration of ox-LDL (25g/mL) for 24h. This 
treatment resulted in a sharp increase of Notch1-4, Jag1, Dll4, Hes1 and Hey2 mRNA, but not Hey1 
(Supplementary material online, Figure S1G). Thus the expression of several Notch pathway genes in 
MAEC is upregulated by pro-inflammatory/pro-atherogenic factors TNFa and ox-LDL, mimicking the 
effect of the HCD.  
 
Inactivation of endothelial Notch slows atherosclerosis progression in ApoE-/- mice 
To determine canonical Notch function in atherosclerosis we crossed mice heterozygous for a targeted 
mutation in the Notch pathway effector RBJK (RBPJ+/-) 20 with atherosclerosis-prone ApoE-/- mice. 21 
Eight-week-old ApoE-/-;RBPJ+/- mice and ApoE-/-;RBPJ+/+ control littermates were fed a HCD for 16 
weeks and examined for the presence of atherosclerotic lesions. En face analysis of Oil-Red O-stained 
aortas showed a 33% smaller average atheroma plaque area in ApoE-/-;RBPJ+/- mice compared with 
controls (Figure 2A,D) independently of plasma cholesterol levels (Supplementary material online, 
Figure S2A-C), suggesting that Notch-RBPJ signalling is required for atherosclerotic plaque formation. 
To determine the implication of the Notch1 receptor in this effect, we generated ApoE-/-;Notch1+/- and 
ApoE-/-;Notch1+/+ control littermates and fed them the HCD. En face analysis of Oil-Red O-stained aorta 
revealed an average 2-fold-smaller plaque area in ApoE-/-;Notch1+/- mice compared with ApoE-/-
;Notch1+/+ control littermates (P<0.05; Figure 2B,D), suggesting that Notch1 is indeed responsible, at 
least in part, for the pro-atherogenic effect of Notch signalling. 
 To establish if atheroma formation depends on Notch function in the endothelium, we crossed the 
inducible endothelial-specific Cre driver line Cdh5-CreERT 22 with floxed RBPJ mice 23 in the ApoE-/- 
background. Eight-week-old ApoE-/-;RBPJflox/flox;Cdh5-CreERT and control ApoE-/-;RBPJflox/flox littermates 
were administered 4-hydroxytamoxifen (4-OHT) for 5 consecutive days to induce RBPJ recombination 
and were subsequently fed the HCD. Abrogation of Notch signalling in the aortic endothelium of  
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ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice was verified by downregulated expression of Notch pathway 
elements (Supplementary material online, Figure S3). In situ hybridization (ISH) revealed markedly 
lowered mRNA expression of endothelial Notch1 and Hey2 (Supplementary material online, Figure 
S3B,E) and endothelial immunoreactivity for Jag1, N1ICD and Hes1 was also strongly diminished in 
aortic sections of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice (Supplementary material online, Figure 
S3A,C,D).  
En face analysis of Oil-Red O-stained aorta revealed an average 3-fold smaller plaque area in 
ApoE-/-;RBPJflox/flox;Cdh5- CreERTmice compared with ApoE-/-;RBPJflox/flox control littermates  (P<0.01; 
Figure 2C,D), despite similar serum lipoprotein profiles (Supplementary material online, Figure S2D-F), 
Movat’s pentachrome staining of aortic root cross sections confirmed a marked reduction in atheroma 
plaque formation in ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice with respect to controls (P<0.01; Figure 
2D,E). 
To quantify disease progression, atherosclerotic lesions were grouped into 3 categories of increasing 
severity, as previously described 24, 25. ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice presented a higher 
proportion of early plaques (48%) and relatively few advanced plaques (15%). Conversely,  
ApoE-/-;RBPJflox/flox control mice had a higher proportion of advanced plaques (72%) and a lower 
proportion of early plaques (10%) (Figure 2F), suggesting that endothelial Notch deletion slows 
atherosclerosis progression. Consistent with this finding, the most advanced plaques in ApoE-/-
;RBPJflox/flox;Cdh5- CreERT mice contained fewer apoptotic cells than their counterparts in ApoE-/-
;RBPJflox/flox mice, as assessed by TUNEL assay (Figure 2G,J).  
 
Endothelial Notch inactivation impairs leukocyte rolling and homing and vascular adhesion 
molecule expression  
To investigate the effect of Notch on myeloid cell recruitment we monitored leukocyte adhesion and 
immune-cell composition in plaques. Atherosclerotic lesions of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice had 
a below-control macrophage content (P<0.05; Figure 2H-J and Supplementary material online, Figure 
S4A,B) but a normal CD3+ T cell content (Supplementary material online, Figure S4C,D). Flow 
cytometry analysis of the whole aorta revealed a decrease of Gr1-CD115+ monocytes (P=0.036) in ApoE-/-
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;RBPJflox/flox;Cdh5-CreERT mice with respect to their WT ApoE-/-;RBPJflox/flox counterparts (Supplementary 
material online, Figure S4E). However with regard to the total number of circulating cells, the total 
number of circulating T cells (CD3+), B cells (CD45R+), patrolling monocytes (Gr-CD115+), 
inflammatory monocytes (Gr+CD115+) and neutrophils (Gr+ CD115-) were similar in  
ApoE-/-;RBPJflox/flox;Cdh5-CreERT and ApoE-/-;RBPJflox/flox mice (Supplementary material online, Figure 
S4F). Moreover, the proportion of Lin- ckit+ sca1+ bone marrow hematopoietic stem cells was also 
relatively similar in both groups (Supplementary material online, Figure S4G).   These data suggest that 
the paucity of macrophages in the plaques of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice is due to reduced 
leucocyte recruitment rather than impaired production of circulating cells.  
 To examine the role of endothelial Notch signalling in leukocyte rolling, we grafted BM from 
ApoE-/-;Mafia transgenic mice into ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice and ApoE-/-;RBPJflox/flox 
littermates, to allow easy identification of GFP-positive circulating monocytes and neutrophils 26. After 
total reconstitution, mice were fed a HCD for 3 weeks, and the carotid arteries were examined by 
intravital microscopy (Figure 3A). Leukocyte rolling flux was decreased in  
ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice compared with control ApoE-/-;RBPJflox/flox littermates, whereas 
rolling velocity was faster (Figure 3B,C and Supplementary material online, Online Movies 1 and 2). 
Consistent with reduced leukocyte rolling, there was reduced GFP immunostaining in the aortic-roots of 
ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice (Figure 3D and E). 
 Leukocyte homing was examined by injecting nucleated BM cells from ApoE-/-;Mafia mice into 
HC-fed ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice and control littermates. Aortic-arch GFP mRNA 
expression after 24 hours was lower in ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice than in controls (Figure 
3F), reflecting lower recruitment of GFP+ myeloid leukocytes. To determine the mechanism underlying 
the reduced rolling and migration, we incubated BCEF-AM-labelled leukocytes (see Online Suppl. 
Material) with TNF-stimulated MAEC derived from ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice or littermate 
controls; fewer leukocytes adhered to the RBPJ-deleted MAEC than to controls (Figure 3G). Moreover, 
the impaired leukocyte adhesion correlated with low Icam1 and Vcam1 expression in TNF-stimulated 
MAEC (Figure 3H). Consistent with these data, treatment with the -secretase inhibitor DAPT 27 
decreased leukocyte adhesion to bovine aortic endothelial cells (BAEC) (Figure 3I) and reduced Icam1 
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and Vcam1 transcription (Figure 3J). Taken together, our data suggest that Notch signalling in the 
endothelium promotes myeloid leukocyte recruitment by sustaining the expression of Icam1 and Vcam1. 
 
Endothelial RBPJ ablation attenuates the atherogenic inflammatory programme 
To investigate the effector pathways of the Notch-dependent inflammatory response in atherosclerosis, 
we compared mRNA expression in aortic arches of ApoE-/-;RBPJflox/flox;Cdh5-CreERT and ApoE-/-
;RBPJflox/flox mice by RNA sequencing (RNA-seq). This study identified a total of 1922 differentially 
expressed genes (P<0.05), of which 1209 were upregulated in of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice 
and 713 downregulated (Supplementary material online, Table S1).  
 Ingenuity Pathway Analysis (IPA) identified multiple functions and pathways altered in ApoE-/-
;RBPJflox/flox;Cdh5-CreERT mice (Figure 4 and Supplementary material online, Table S2). A selection of 81 
differentially expressed transcripts associated to six biological functions defined by Gene Ontology (GO) 
are shown in Figure 4A. Many upregulated genes were associated with cell-to-cell interactions and 
survival, such as those encoding tight junction or gap-junction proteins like Tjp1, Cldn25 and Gjc1 and 
the survival genes Rictor, Akt3 and Bcl2, perhaps reflecting changes of vascular permeability. To examine 
endothelial barrier function in ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice, we performed Evans blue vascular 
permeability assay (Supplementary material online, Figure S5). We found no significant difference in 
Evans blue staining or dye content in ApoE-/-;RBPJflox/flox;Cdh5-CreERT with respect to ApoE-/-;RBPJflox/flox 
mice (Supplementary material online, Figure S5A,B), suggesting that endothelial barrier function was not 
impaired. 
In contrast, there was a severe downregulation of genes implicated in cellular processes related to 
inflammation (Figure 4A), notably those required for leukocyte-endothelium interaction and leukocyte 
extravasation. Thus chemokine receptors (Cxcr2), cellular mediators of monocyte/macrophage activation 
like Ccl2 (MCP1), Ccl7, Ccl12, Ccl4, Cxcl1 and Ccl3 (Figure 4A) and leukocyte adhesion proteins like P-
Selectin (Selp) and E-Selectin (Sele) were sharply decreased. These latter factors are expressed on 
activated endothelial cells shortly after cytokine activation by tissue macrophages. Other genes involved 
in immune cell movement and trafficking, such as integrin ligands Vcam1 and Icam1 were also 
downregulated (Figure 4A), consistent with our prior in vitro observations (Figure 3H and J). 
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Attenuation of the global inflammatory response was further evidenced by decreased expression of 
classical mediators of immunity, including interleukins and their corresponding receptors (Il1b/Il1r2, 
Il6/Il6r, Tnf/Tnfrsf1b). Importantly, the aortic arch of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice showed 
significant downregulation of members of pathways previously associated with atherosclerosis, such as 
prototypical components of the NF-kB signalling pathway (RelB, Nfkbie, Nfkbid, Nfkb2 and Nfkbia), 
matrix metalloproteases (including Mmp2 and Mmp14, and Timp1), and Toll-like receptors pathways 
(Tlr1, Tlr2 and Tlr6; Figure 4A). Interestingly, among the upregulated genes important for the 
inflammatory response, Tgf3 and its receptor Tgfb3r were reported previously in relation to 
atherosclerosis development in ApoE-/- mice 28. These findings were confirmed by canonical pathways 
analysis (Supplementary material online, Table S2). For example, the NF-kB, IL6, acute phase 
inflammatory response, and Toll-like receptor pathways were all significantly downregulated, whereas 
Tgf was upregulated (Figure 4B). Changes in the expression of several key genes implicated in 
endothelial activation and inflammation were validated by qRT-PCR (Figure 4C) and/or 
immunohistochemistry (Figure 4D-F).  
The RNA-seq also detected differential modulation of genes associated with cellular growth and 
proliferation; for example, the cell-cycle inhibitor CDKN1A (p21) was downregulated, whereas 
CDKN1B (p27) was upregulated (Figure 4A and Supplementary material online, Table S1), consistent 
with CDKN1A being atherogenic and CDKN1B atheroprotective 29. Nevertheless, proliferation measured 
by Ki67 staining in plaques from ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice was not significantly different 
from control (Supplementary material online, Figure S5C,D). Taken together, the RNA-seq data analysis 
indicates that endothelial-specific Notch ablation suppresses the proinflammatory genetic programme 
associated with atherosclerosis. 
 
Notch interacts with NF-kB in endothelial cells and facilitates NF-kB nuclear localization 
Many of the putative RBPJ target genes identified by RNA-seq are also targets for NF-kB (nuclear factor 
kappa B; http://bioinfo.lifl.fr/NF-KB/). NF-kB is a family of transcription factors whose predominant 
form, p65/p50, is maintained in an inactive state in the cytoplasm through interaction with Ikbka 30. In 
response to inflammatory stimuli elicited by cytokines such as TNF, Ikbka is phosphorylated by the 
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IKK complex and releases p65/p50, which translocates to the nucleus and activates transcription of genes 
containing kB sites in their promoter 30. Given that endothelial NF-kB signalling activation is critical for 
inflammation and atherogenesis in mice 24, we hypothesized that Notch might act upstream of, or in 
parallel with, NF-kB to regulate common target genes. 
 Studies in different cellular systems have determined that the physical interaction between 
N1ICD and NF-kB facilitates NF-kB nuclear translocation and/or retention 31-36. To determine if N1ICD 
promotes NF-kB nuclear translocation in endothelial cells, we monitored the levels of nuclear and 
cytoplasmic NF-kB-p65 protein over time in response to TNF. After 30 min in the presence of TNF 
the proportion of nuclear NF-kB-p65 staining was markedly reduced (P<0.01) in ApoE-/-
;RBPJflox/flox;Cdh5-CreERT MAEC compared to ApoE-/-;RBPJflox/flox MAEC (Figure 5A,B), whereas the 
proportion of nuclear and cytoplasmic staining was higher (P<0.05), suggesting that p65 nuclear 
translocation is blocked or delayed in MAEC lacking RBPJk. In addition, analysis of nucleo-cytoplasmic 
fractions by Western blot indicated that  TNFα-stimulated NF-kB-p65 nuclear accumulation after 30 
min was 2.5-fold increased in  ApoE-/-;RBPJflox/flox MAEC compared to 2-fold in ApoE-/-;RBPJflox/flox;Cdh5-
CreERT MAEC (Figure 5C,D). Delayed TNF-induced p65 nuclear entry was also observed after treating 
human umbilical vein endothelial cells (HUVEC) with the -secretase inhibitor RO4929097 37 
(Supplementary material online, Figure S6A-D). 
N1ICD is known to facilitate NF-kB nuclear translocation in cancer cells and valve aortic 
interstitial cells by interacting with the IKK complex 34-36. To determine if N1ICD-IKK interaction 
increases the nuclear presence of NF-kB-p65 in endothelial cells, we immunoprecipitated N1ICD from 
porcine aortic endothelial cells (PAEC) overexpressing a myc-tagged version of N1ICD 27. IKK and 
N1ICD were co-immunoprecipitated from untreated PAEC N1ICD cells, and this interaction was 
enhanced by treatment with TNF (Figure 5D). Myc-tagged N1ICD from PAEC also co-
immunoprecipated NF-kB-p65/p50 (Figure 5E), and TNF stimulation also increased N1ICD binding to 
NF-kB-p65 and the amount of immunoprecipated NF-kB in HUVEC (Figure 5F). Taken together, these 
results indicate that N1ICD can bind to both IKK and NF-kB-p65. Its interaction with NF-kB-p65 is 
enhanced by proinflammatory signals  and promotes NF-kB nuclear localization in endothelial cells.  
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N1ICD and NF-kB coactivate the inflammatory response in endothelial cells 
An anticipated functional outcome of increased nuclear NF-kB-N1ICD complex formation is that the 
transactivation of target genes common to both NFkB and N1ICD is more sustained or prolonged. 
Treating HUVEC with TNF resulted in marked induction of VCAM-1, ICAM-1, SELE and NFKB2 and 
NFkBI expression (Figure 6A). This effect was almost completely abolished by pre-treating cells with 
the chemical NF-kB inhibitor BAY-11-7082 (BAY-11) (Figure 6A). TNF also increased the expression 
of JAG1 and HEY1, and this effect was blocked by BAY-11 (Figure 6A), suggesting that the expression 
of TNF-induced Notch-pathway genes is dependent on NF-kB activation. These results were confirmed 
by western analysis of JAG1 and VCAM1 (Figure 6B). BAY-11 only partially reduced JAG1 levels, 
suggesting that JAG1 protein levels depend on additional factors (Figure 6B). These data suggest NF-kB 
activation is required for the TNF-mediated stimulation of target gene transcription by both NF-kB and 
NOTCH pathways. 
We next examined the effect of RBPJ genetic disruption upon TNFα stimulation in MAEC. In 
ApoE-/- MAEC, TNFα  sustains the mRNA and protein expression of Notch pathway components 
(Notch1, Notch2, Notch4, Jag1, Dll4, Hes1, Hey1 and Hey2) and Vcam1, Icam1 (Figure 3H) and Nfkbi 
(Figure 6C,D). However this effect was suppressed in ApoE-/-;RBPJflox/flox;Cdh5-CreERT MAEC, indicating 
that RBPJ is required for TNF-induced gene expression in MAEC . Consistent with this, TNF 
induction of Notch and NF-kB targets in BAEC was partially blocked by DAPT (Supplementary material 
online, Figure S6E,F). Accordingly, NF-kB luciferase reporter activity increased 3.5-fold in BAEC in 
response to TNF, and this effect was reduced to 2-fold by pre-treating with DAPT (Figure 6E). These 
data suggest that Notch activation is required for TNFα-stimulated expression of NF-kB and Notch 
target genes.  
 To determine if increased NICD-RBPJ signalling can activate NF-kB independently of TNF, we 
cultured HUVEC on plastic dishes coated with the extracellular domain of the NOTCH ligand JAG1. 
JAG1 ligand stimulation induced the NOTCH target genes DLL4, JAG1, HES1 and HEY1 as well as 
several NF-kB target genes, including VCAM1, ICAM1, SELE, NFKB2 and NFKBI (Figure 6F), 
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indicating that NOTCH activation by JAG1 can lead to the upregulation of NF-kB target genes. To 
determine whether the effects of JAG1 and TNF were additive, we cultured HUVEC with TNF alone 
or together in presence of immobilized JAG1 extracellular domain. Although NFKB2 was not affected, a 
combination of TNF and JAG1 induced an average 2-fold increase in the activation of the NOTCH and 
NF-kB target genes JAG1, HEY1, ICAM1, VCAM1, SELE, and NFKBI compared with the effect of 
TNF alone (Figure 6G). These results suggest that the effects of TNF and JAG1 are additive. Taken 
together, our data indicate that TNF-stimulated transcription of NF-kB and NOTCH target genes 
requires the concerted activation of NICD-RBPJ and NF-kB signalling. 
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Discussion 
In this study we addressed the role of canonical (RBPJ-mediated) Notch signalling in the adult 
endothelium and identified an important and unexpected pro-atherogenic Notch function in 
atherosclerosis. Thus, endothelial-specific deletion of Notch signalling in ApoE-/- mice  
(ApoE-/-;RBPJflox/flox;Cdh5-CreERT ) causes a marked delay in atherosclerosis progression, a finding 
confirmed by in vitro experiments. Multiple lines of evidence support the notion that endothelial Notch 
signalling is pro-atherogenic: i) Notch pathway components expression is upregulated in atherosclerotic 
lesions of CAD patients; ii) endothelial Notch inactivation in ApoE-/- mice decreases adhesion molecule 
expression, leukocyte recruitment, macrophage accumulation and attenuates atheroma plaque severity; iii) 
endothelial Notch inactivation decreases NFB-dependent gene expression, impairing the pro-
inflammatory response; and iv) Notch signalling promotes the pro-inflammatory/pro-atherogenic 
response mediated by NFB both in vivo and in vitro. 
We find, consistent with a prior study 38 that Notch signalling components are upregulated in 
luminal ECs of human atherosclerotic plaques, supporting a role for this developmental pathway in 
human CAD. We demonstrate that endothelial Notch inactivation slows the progression of atherosclerosis 
in ApoE-/- mice. Notch signalling activation is required for the inflammatory response elicited in the 
endothelium, but persistent activation in vivo is ultimately detrimental because it results in the chronic 
inflammatory process underlying atheroma plaque build-up. Previous models of artery injury and studies 
in endothelial cell cultures have pointed to a protective role of the Notch pathway in atherosclerosis 39, 40. 
More recently, Notch pathway gene expression was found to be downregulated in C57/BL6 mice on 
short-term high fat diet and in human aortic endothelial cells (HAEC) exposed to ox-PAPC or 
inflammatory cytokines 41. This effect was linked to increased monocyte binding and diet-induced 
atherosclerosis in L-sIDOL mice 42 with heterozygous deletion of Notch1 41. These contrasting data may 
reflect differences in model systems and experimental conditions (short-term versus long-term diets; 
acute versus chronic inflammation; different origins of the endothelial vascular bed and inter-individual 
variation) and the complexity of Notch signalling functions, canonical or non-canonical, which are highly 
context dependent 7.  
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A pro-atherogenic effect of canonical Notch signalling in the endothelium is supported by the 
RNA-seq data. We detected significant downregulation of adhesion molecules, remodelling enzymes, and 
proinflammatory pathways in ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice, consistent with lower incidence of 
atherosclerosis and the requirement of endothelial Notch signalling for the inflammatory response. MMPs 
weaken the arterial wall and contribute to destabilization and rupture of atherosclerotic plaques 43. 
Chemokines and their receptors support leukocyte arrest on the endothelium, form chemotactic gradients 
that promote diapedesis and provide important anti-apoptotic survival cues to leucocytes 44. Interleukins, 
their receptors, TNF pathway components and TLRs are all implicated in the inflammatory response 45. 
TLRs recognize pathogens and mediate signalling pathways important for host defense and their effects 
are not limited to inflammatory cells because they can also alter the behaviour of resident vascular cells 
46. In summary, our RNA-seq data suggest that the inactivation of RBPJ in the endothelium negatively 
impacts key inflammatory processes involved in atherosclerosis progression. 
The NF-kB pathway was prominently downregulated after endothelial RBPJ deletion. NF-kB is a 
master regulator of inflammatory responses, both in the initial stages of inflammation and in the 
resolution phases 47, 48. Moreover, NF-kB regulates atheroma formation 48, 49 and a signalling mechanism 
driving atherosclerotic plaque progression in the endothelium 24. A complex and incompletely understood 
interplay between Notch and NF-kB has been described in several cell types and contexts, including B 
cell differentiation, inflammation, injury, and cancer. Depending on the situation, this interplay can lead 
to either activation or repression of gene transcription 50. In the context of inflammation, Notch and NF-
kB interaction leads ultimately to transcriptional activation. For example, cooperation between Notch and 
NF-kB in macrophages is essential for the expression of interleukins 51, 52 and inflammatory-associated 
molecules 53 and for macrophage activation 54-56. Mechanistically, this synergism has been shown to occur 
through protein-protein interaction in the cytoplasm that facilitates shuttling to the nucleus 34-36 or through 
protein-protein interaction in the nucleus that promotes nuclear retention 33. Moreover, N1ICD binding to 
NF-kB has been shown to stabilize NF-kB and enhance its binding to target gene promoters 31, 32.  
Manipulating Notch and NF-kB activities allowed us to extend many of these findings to 
endothelial cells by establishing that the nuclear content of NF-kB-p65 is markedly below normal in 
endothelial cells lacking RBPJ. This implies that RBPJ and NF-kB interact functionally, consistent with 
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findings in macrophages and other cell systems 31-34, 36, 57. RBPJ and NF-kB-p60 may interact through 
N1ICD, since N1ICD can physically bind to NF-kB-p60 (Figure 5E,F). Future studies combining ChIP-
seq with RNA-seq should shed light on the mechanism of transcriptional co-regulation and identify the 
full repertoire of genes controlled by Notch and/or NF-kB in endothelial cells. Taken together, our 
findings support a model of tight integration between the NF-kB and Notch pathways early upon TNF 
stimulation, in which N1ICD acts as a transcriptional co-factor of NF-kB and establishes an auto-
amplification loop through Jag1 that heightens NF-kB signalling (Figure 7). Initially, NF-kB-dependent 
Jag1 induction in endothelial cells may be mediated by signals emanating from interacting mononuclear 
cells. Supporting this idea, cell surface expression of Jag1 in c-Rel-expressing cell monolayers 
functionally interacts with lymphocytes expressing the Notch1 receptor 58-60. Given that Jag1 expression 
is widespread in immune cells and tissues 58-60, signalling to Notch1-expressing endothelial cells is also 
likely. Subsequently, coactivation of Jag1 expression by Notch and NF-kB augments and sustains a 
subset of NF-kB-inducible genes that are Notch dependent. In a similar fashion, Jag1-mediated cross-
amplification between TLR and Notch is required in primary macrophages for the early phases of TLR-
induced gene expression and induction of Notch ligands that can modulate later phases of the TLR 
response 60, 61. Moreover, feed-forward signalling between Jag1/Notch and NF-kB may constitute a 
“priming” mechanism that ensures rapid propagation of the inflammatory response from locally athero-
susceptible regions to the rest of the endothelium. 
The graded pattern of N1ICD expression, between athero-prone ApoE-/- and relatively athero-
resistent C57/BL6 mice on one hand, and sites of atheroma formation in fat-fed ApoE-/- mice on the other 
(Figure 1), suggests that N1ICD expression and disease progression are linked and that a Notch-
dependent inflammatory programme precedes overt disease. This possibility could be examined in 
juvenile ApoE-/- mice, which experience low-level inflammation but show no signs of atheroma formation 
before 4 weeks of age 62. Early detection of endothelial NOTCH activation may have prognostic value in 
atherosclerosis, given that endothelial activation and subsequent dysfunction contributes to 
atherosclerosis severity and progression 2, 63-65. Moreover, strategies that aim to attenuate NOTCH 
signalling in the endothelium should be taken into consideration to complement current anti-inflammatory 
therapies for atherosclerotic vascular disease. Jag1 constitutes a potential early therapeutic target for the 
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blockade of atherosclerosis and development of coronary artery disease. Immune targeting of Jag1 may 
provide a potential future strategy for the prevention of atherosclerosis progression either alone or in 
combination with standard treatments. 
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Figure  Legends 
Figure 1. Notch signalling is upregulated in human and mouse atherosclerosis. (A) Representative 
western blot showing protein levels of NOTCH1 (full-length and cleaved form or N1ICD), JAG1 and 
HES1 in atherosclerotic and non-atherosclerotic human coronary arteries. (B) Real time-PCR analysis of 
NOTCH signalling genes in atherosclerotic (n=15) and non-atherosclerotic (n=10) human coronary 
arteries. Data are means ± SEM. *P<0.05; **P<0.01; ***P<0.001.  (C-F) Representative sections of 
aortic sinus at non-atherosclerotic and atherosclerotic sites in C57/BL6 and ApoE-/- mice. (C) Jag1 
immunohistochemistry (IHC). (D) Notch1 in situ hybridization (ISH). (E) N1ICD immunofluorescence. 
(F) Hes1 IHC. Arrowheads point to endothelial cells and arrows to putative immune cells. Representative 
of two independent experiments. Scale bars, 50μm. 
 
 Figure 2. Endothelial deletion of RBPJ delays atherosclerosis progression in ApoE-/- mice. (A) 
Representative Oil-red-O en face staining of aortas of ApoE-/-;RBPJ+/+ and ApoE-/-;RBPJ+/- mice (6-8 
weeks-old) fed a HC diet for 4 months. (B) Representative Oil-red-O en face stainings of aortas of ApoE-/-
;Notch1+/+ and ApoE-/-;Notch1+/- mice (6-8 weeks-old) fed a HC diet for 6 weeks. (C) Representative Oil-
red-O en face stainings of aortas of ApoE-/-;RBPJflox/flox and ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice (6-8 
weeks old) induced with 4-hydroxy-tamoxifen on 5 consecutive days and fed a HCD for 6 weeks. (D) 
charts show plaque quantification in aortic arches of ApoE-/-;RBPJ+/+ (n=7) and ApoE-/-;RBPJ+/- (n=5) 
mice; quantification in aortic arches of ApoE-/-;Notch1+/+ (n=7) and ApoE-/-;Notch1+/- (n=6) mice; 
quantification in aortic arches of ApoE-/-;RBPJflox/flox (n=12) and ApoE-/-;RBPJflox/flox;Cdh5-CreERT (n=9) 
mice and quantification of atherosclerotic lesion area in ApoE-/-;RBPJflox/flox (n=13) and ApoE-/-
;RBPJflox/flox;Cdh5-CreERT (n=22) mice. (E) Representative Movat’s pentachrome staining of transverse 
sections of the aortic sinus in ApoE-/- and ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice; scale bars, 50 μm; chart 
shows (F) Histological staging of atherosclerotic lesions of ApoE-/-;RBPJflox/flox and  
ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice (n=5 per group). The pie chart shows the mean percentage of each 
type of lesion (early, moderate and advanced) as a percentage of the total atherosclerotic plaque area in 
each mouse (n=5 mice per genotype). (G) Representative TUNEL assay on transverse sections of aortic 
sinus of ApoE-/-;RBPJflox/flox and ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice. Arrowheads point to TUNEL-
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positive cells; scale bars, 50m. (H,I) Representative F4/80 immunohistochemistry (brown stain) in 
transverse sections of aortic sinus of ApoE-/-;RBPJflox/flox (H) and ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice (I) 
and higher magnifications of inset areas. Scale bars, 100m. (J) Quantification of TUNEL positive nuclei 
(n=4 per group) and of F4/80-positive area in aortic sinus sections of ApoE-/-;RBPJflox/flox and  
ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice (n=5 per group). For all the charts, data are means ± SEM. 
*P<0.05; **P<0.01; ***P<0.001.   
  
Figure 3. Endothelial deletion of RBPJ results in reduced leukocyte recruitment to atheroma-prone 
regions of the carotid artery. (A) Intravital microscopy image capture of carotid bifurcation in the FITC 
channel at low magnification. White dashed lines delimit the carotid artery wall. Green dashed lines show 
areas imaged for the quantification of rolling. White arrow indicates blood flow. Scale bar, 100 m. (B) 
Quantification of rolling GFP+ myeloid leukocytes in ApoE-/-;RBPJflox/flox and ApoE-/-;RBPJflox/flox;Cdh5-
CreERT mice transplanted with bone marrow from ApoE-/-;Mafia transgenic mice (GFP+ myeloid 
leukocytes). Results are normalized to the control group mean (n=15-18 fields from 5 mice/group). Long 
horizontal lines denote mean values, and error bars denote SEM (each data point denotes a field). (C) 
Quantification of rolling velocity of GFP+ myeloid leukocytes in transplanted ApoE-/-;RBPJflox/flox and 
ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice [n=68-82 leukocytes from fields presented in (B)]. (D) 
Representative GFP immunostaining of atherosclerotic plaques in the aortic root of ApoE-/-;RBPJflox/flox; 
Cdh5-CreERT and ApoE-/-;RBPJflox/flox mice (n=5 per group) transplanted with BM from ApoE-/-; Mafia 
transgenic mice and fed a HC diet for 3 weeks. Elastic fibres display autofluorescence. Scale bar, 25m. 
(E) Numbers of GFP+ cells (neutrophils and macrophages) in atherosclerotic plaques of animals described 
in (D). (F) Relative GFP mRNA expression in aortic arches of ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice and 
ApoE-/-;RBPJflox/flox littermates (n=5, each group) 24 h after injection with GFP+ nucleated bone marrow 
cells. (G) Quantification of leukocyte adhesion on MAEC derived from ApoE-/-;RBPJflox/flox and  
ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice treated with TNFα  for 12h. Data represent three biological 
replicates in two independent experiments. (H) Relative expression of Icam1 and Vcam1 mRNA in 
MAEC derived from ApoE-/-;RBPJflox/flox and ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice treated with TNFα 
for 24h. Data represent three biological replicates in two independent experiments. (I) Quantification of 
by guest on August 16, 2016
D
ow
nloaded from
 
21 
leukocyte adhesion on BAEC exposed to 10 µM DAPT or vehicle (DMSO) after treatment with TNFα 
for 24h. Data represent three biological replicates in two independent experiments. (J) Relative 
expression of Icam1 and Vcam1 mRNA in BAEC exposed to 10 µM DAPT or vehicle (DMSO) after 
treatment with TNFα  for 24h. Data represent two independent experiments with three biological 
replicates. For all the charts, data are means ± SEM. *P<0.05; **P<0.01; ***P<0.001.   
 
Figure 4. Downregulation of proinflammatory gene expression in ApoE-/-;RBPJflox/flox; Cdh5-CreERT 
mice. (A-C) Global gene expression analysis and validation. (A) Circular plot of selected deregulated 
genes in ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice compared with ApoE-/-;RBPJflox/flox mice (n=3 per group) 
identified by RNA-seq. The analysis identified 81 differentially expressed genes belonging to various 
biological processes relevant to this study. The left semicircle represents differentially regulated genes 
and the right semicircle represents biological processes. The gene-expression colour scheme represents 
the logFC for each gene plotted: downregulated in blue and upregulated in red. (B) Analysis of canonical 
pathways for the deregulated genes in ApoE-/-;RBPJflox/flox;Cdh5-CreERT aortic arches. Bars represented -
log (B-H P value, Benjamini-Honchberg-adjusted P value). Colour code in bars reflects the direction of 
change for the function, based on z-score (orange, positive z-score: the pathway is trending towards an 
increase; blue, negative z-score: the pathway is trending towards a decrease). The ratio indicates the 
number of differentially expressed genes in a given pathway divided by the total number of genes listed 
in that pathway. (C) Relative mRNA expression of indicated genes measured by qRT-PCR. Data are 
means ±SEM (n=4-5 aortas per group). (D-F) Representative sections of aortic sinus of ApoE-/-
;RBPJflox/flox;Cdh5-CreERT and ApoE-/- mice immunostained for (D) Icam1, (E) Vcam1 and (F) NF-kB-
p65. ApoE-/-;RBPJflox/flox;Cdh5-CreERT aortas show lower staining of the luminal endothelial layer 
(arrowhead). Note that Icam1 and NF-kB immunoreactivity is also detected in immune cells within 
atherosclerotic plaques (arrow). Representative of two independent experiments. Scale bars, 50 μm.  
 
Figure 5. N1ICD interacts with NF-kB-p65 (RelA) and is required for its translocation/retention in 
the nucleus. (A) NF-kB-p65 immunofluorescence in ApoE-/-; RBPJflox/flox and ApoE-/-;RBPJflox/flox;Cdh5-
CreERT MAEC without stimulation (t0) and after exposure to TNF  for 30 min . Representative images 
by guest on August 16, 2016
D
ow
nloaded from
 
22 
of two independent experiments. Scale bar, 30 m. (B) Quantification of cytosolic, cytosolic and nuclear, 
and nuclear NF-kB p65 staining (ImageJ) in (A), *P<0.05; **P<0.01. (C) Western blot (WB) detecting 
nuclear (N), and cytosolic (C) fractions of NF-kB-p65 in ApoE-/-;RBPJflox/flox and  ApoE-/-
;RBPJflox/flox;Cdh5-CreERT MAEC exposed to TNF at the indicated time points. One of two independent 
experiments is shown. (D) Quantification of western-blot band density (ImageJ). White dots correspond 
to values determined for different time points shown in (C). Black dots correspond to values determined 
in the replicate Western blot (not shown). (E) PAEC were exposed to TNF for 1 h. (Top panel) 
Immunoprecipitation (IP) with anti-IKK antibody, WB against N1ICD-Myc. (Bottom panel) Whole cell 
extract (WCE) immunoblot to detect IKK. One of two independent experiments is shown. (F) (Top 
panel) IP with anti-myc antibody, WB with anti-NF-kB-p65.  (Bottom panel) WCE immunoblot to detect 
NF-kB-p65. One of two independent experiments is shown. (G) (Top two panels) HUVEC were exposed 
-NF-kB-p65 antibody and WB with anti-N1ICD or anti-NF-kB-
p65. (Bottom two panels) WCE immunoblots to detect N1ICD or NF-kB-p65. One of two independent 
experiments is shown.  
 
Figure 6. TNF-dependent transcription of Notch- and NF-kB-target genes in endothelial cells 
requires mutual activation of both pathways. (A) qRT-PCR analysis of the relative mRNA expression 
of indicated genes in HUVEC pretreated with BAY-11 (10M) or vehicle (DMSO) for 1h and exposed to 
TNF for 3h. One of two independent experiments, each with three biological replicates, is shown. (B) 
Immunodetection of JAG1 and VCAM1 proteins in HUVEC pretreated for 1h with BAY-11 (10M) or 
DMSO and exposed to TNF for 8h. One of two independent experiments is shown. (C) Relative mRNA 
expression of indicated genes as detected by qRT-PCR in MAEC exposed to TNF for 3h. One of two 
independent experiments, each with three biological replicates, is shown. (D) Immunodetection of Jag1, 
Hes1 and Vcam1 protein in MAEC from ApoE-/-;RBPJflox/flox and ApoE-/-;RBPJflox/flox;Cdh5-CreERT mice 
exposed to TNF for 8h. One of two independent experiments is shown. (E) Activity of the 3XNF-kB-
Luciferase reporter construct in BAEC exposed to TNFα for 8 hours in the presence of DAPT or DMSO. 
Results are representative of three independent experiments, each with six biological replicates. (F) qRT-
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PCR analysis of relative mRNA expression of the indicated genes in HUVEC plated for 24 hours on 
JAG1-coated or control plates. Results represent three replicates in two independent experiments. One of 
two independent experiments, each with three biological replicates, is shown. (G) qRT-PCR analysis in 
HUVEC plated for 24 hours on JAG1-coated plates and exposed to TNF for 8 hours. One of two 
independent experiments, each with three biological replicates is shown. For (A, C, E, F and G), data are 
means ± SEM. *P<0.05; **P<0.01; ***P<0.001; n.s., non significant. 
 
Figure 7. Model of Notch and NF-kB signalling crosstalk in the proinflammatory endothelium. (a) 
Exposure to TNFα  activates the NF-kB signalling pathway in endothelial cells. (b) NF-kB-p65 
translocates to the nucleus and upregulates its target genes, including Jag1. (c) Jag1 engages with Notch1 
in adjacent cells, resulting in N1ICD release from the cell membrane. (d) N1ICD binds to IKKα, 
promoting NF-kB-p50/p65 translocation to or retention in the nucleus. (e) N1ICD binding to RBPJ in the 
nucleus activates Notch target genes, including Jag1. (f) NF-kB-p65 interacts with N1ICD-RBPJ to 
activate a subset of Notch-dependent NF-kB target genes, including Jag1, generating a positive feedback 
loop between Notch and NF-kB signalling. 
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